Tempol Clinical Trials

1 actively recruiting trial across 1 location

Also known as: 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl

Pipeline

Phase 2: 1

Top Sponsors

Matrix Biomed, Inc.1

Indications

Ototoxicity1
Mucositis1
Nephrotoxicity1
Cancer1

La Jolla, California1 trial

Treatment of Radiation and Cisplatin Induced Toxicities with Tempol

UCSD

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.